Quick Answer
SeaStar Medical Holding Corp reported Diluted EPS of $6.63 per share (loss) for fiscal year 2024.
SeaStar Medical Holding Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$6.63 | +78.1% |
| 2023 | -$30.26 | -1944.6% |
| 2022 | -$1.48 | -134.9% |
| 2021 | -$0.63 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | -$0.18 | +82.5% | +59.1% |
| March 31, 2025 | -$0.44 | +90.7% | +60.0% |
| September 30, 2024 | -$1.10 | +87.8% | -6.8% |
| June 30, 2024 | -$1.03 | +74.9% | +78.2% |
| March 31, 2024 | -$4.73 | -775.9% | +47.6% |
| September 30, 2023 | -$9.02 | -3369.2% | -120.0% |
| June 30, 2023 | -$4.10 | -3316.7% | -659.3% |
| March 31, 2023 | -$0.54 | -285.7% | -107.7% |
- SeaStar Medical Holding Corp showed an increase of +78.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2024 period, SeaStar Medical Holding Corp’s diluted eps has declined by 952.4% (from $0.63 per share (loss) to $6.63 per share (loss)).
- The most recent figure is from SeaStar Medical Holding Corp’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: